Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qing Lv

Showing results (571-580 of 580) with videos related to

Pageof 58
Sort By:
You have reached the last page of results.This site can display upto 580 results.
Signal Transduction and Targeted Therapy|February 2, 2022
EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastomaQu-Jing Gai, Zhen Fu, Jiang He, et al.
Cancer Communications (London, England)|March 13, 2026
Vebreltinib for Previously Treated Astrocytoma, <i>IDH</i>-Mutant, Grade 4, and Glioblastoma, <i>IDH</i> Wild-Type with <i>PTPRZ1-MET</i> Fusion Gene: A Multicenter, Phase III Randomized, Open-Label TrialZhaoshi Bao, Yake Xue, Yanhui Liu, et al.
Cell Research|July 9, 2021
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signalingXiao-Ning Zhang, Kai-Di Yang, Cong Chen, et al.
The Journal of Pathology|June 20, 2022
A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytomaWen Yin, Yi-Fang Ping, Fei Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2025
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON StudyJin-Ji Yang, Yu Mu, Zhe-Hai Wang, et al.
Frontiers in Immunology|September 29, 2022
A clinical practice guideline for the screening and assessment of enthesitis in patients with spondyloarthritisXinyu Wu, Dong Liu, Yanfei Li, et al.
Molecular Oncology|April 24, 2026
EDNRB-dependent endothelin signaling reduces proliferation and promotes proneural-to-mesenchymal transition in gliomasDonovan Pineau, Leonor Garcia, Hugo Arnold, et al.
Frontiers in Immunology|November 14, 2024
A guideline on biomarkers in the diagnosis and evaluation in axial spondyloarthritisDong Liu, Ya Xie, Liudan Tu, et al.
Cancer Cell|March 24, 2023
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for gliomaHaofei Liu, Qiwen Zhao, Leyong Tan, et al.
Nature Genetics|December 6, 2011
A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitisZhiming Lin, Jin-Xin Bei, Meixin Shen, et al.
Pageof 58

Showing results (571-580 of 580) with videos related to

Sort By:
Pageof 58
You have reached the last page of results.This site can display upto 580 results.
Signal Transduction and Targeted Therapy|February 2, 2022
EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastomaQu-Jing Gai, Zhen Fu, Jiang He, et al.
Cancer Communications (London, England)|March 13, 2026
Vebreltinib for Previously Treated Astrocytoma, <i>IDH</i>-Mutant, Grade 4, and Glioblastoma, <i>IDH</i> Wild-Type with <i>PTPRZ1-MET</i> Fusion Gene: A Multicenter, Phase III Randomized, Open-Label TrialZhaoshi Bao, Yake Xue, Yanhui Liu, et al.
Cell Research|July 9, 2021
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signalingXiao-Ning Zhang, Kai-Di Yang, Cong Chen, et al.
The Journal of Pathology|June 20, 2022
A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytomaWen Yin, Yi-Fang Ping, Fei Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2025
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON StudyJin-Ji Yang, Yu Mu, Zhe-Hai Wang, et al.
Frontiers in Immunology|September 29, 2022
A clinical practice guideline for the screening and assessment of enthesitis in patients with spondyloarthritisXinyu Wu, Dong Liu, Yanfei Li, et al.
Molecular Oncology|April 24, 2026
EDNRB-dependent endothelin signaling reduces proliferation and promotes proneural-to-mesenchymal transition in gliomasDonovan Pineau, Leonor Garcia, Hugo Arnold, et al.
Frontiers in Immunology|November 14, 2024
A guideline on biomarkers in the diagnosis and evaluation in axial spondyloarthritisDong Liu, Ya Xie, Liudan Tu, et al.
Cancer Cell|March 24, 2023
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for gliomaHaofei Liu, Qiwen Zhao, Leyong Tan, et al.
Nature Genetics|December 6, 2011
A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitisZhiming Lin, Jin-Xin Bei, Meixin Shen, et al.
Pageof 58